Gilead Sciences (NASDAQ:GILD) CFO Sells $432,690.00 in Stock

robot
Abstract generation in progress

Gilead Sciences CFO Andrew Dickinson sold 3,000 shares of company stock for $432,690, reducing his stake by 1.65%. This transaction followed a positive Q4 earnings report where the company beat expectations and increased its quarterly dividend to $0.82 per share. Analysts maintain a “Moderate Buy” rating with a consensus price target of $157.62 for GILD.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments